{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T12:58:08Z","timestamp":1781787488280,"version":"3.54.5"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Steroids"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.steroids.2025.109588","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T16:12:26Z","timestamp":1740759146000},"page":"109588","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Design and discovery of novel heteroaryl substituted pregnenolone derivatives as potent anti-neuroinflammatory agents targeting LPS-stimulated BV-2 microglial cells"],"prefix":"10.1016","volume":"216","author":[{"given":"Siqi","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfeng","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuopo","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huide","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaorui","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.steroids.2025.109588_b0005","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.intimp.2018.05.021","article-title":"A synthetic diosgenin primary amine derivative attenuates LPS-stimulated inflammation via inhibition of NF-\u03baB and JNK MAPK signaling in microglial BV2 cells","volume":"61","author":"Cai","year":"2018","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.steroids.2025.109588_b0010","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.arr.2017.02.004","article-title":"Targeting the TLR4 signaling pathway by polyphenols: a novel therapeutic strategy for neuroinflammation","volume":"36","author":"Rahimifard","year":"2017","journal-title":"Ageing Res. Rev."},{"issue":"2","key":"10.1016\/j.steroids.2025.109588_b0015","doi-asserted-by":"crossref","DOI":"10.2174\/157488909788452997","article-title":"Recent patents in CNS drug discovery: the management of inflammation in the central nervous system","volume":"4","author":"Nimmo","year":"2009","journal-title":"Recent Pat. CNS Drug Discovery"},{"issue":"6","key":"10.1016\/j.steroids.2025.109588_b0020","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3858\/emm.2012.44.6.042","article-title":"A new synthetic chalcone derivative, 2-hydroxy-3',5,5'-trimethoxychalcone (DK-139), suppresses the Toll-like receptor 4-mediated inflammatory response through inhibition of the Akt\/NF-\u03baB pathway in BV2 microglial cells","volume":"44","author":"Lee","year":"2012","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.steroids.2025.109588_b0025","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3389\/fnins.2019.00038","article-title":"Innovative therapy for Alzheimer's disease-with focus on biodelivery of NGF","volume":"13","author":"Mitra","year":"2019","journal-title":"Front. Neurosci."},{"issue":"5","key":"10.1016\/j.steroids.2025.109588_b0030","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/nrn3722","article-title":"Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease","volume":"15","author":"Prinz","year":"2014","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.steroids.2025.109588_b0035","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jphs.2020.01.011","article-title":"Terrein suppressed lipopolysaccharide-induced neuroinflammation through inhibition of NF-\u03baB pathway by activating Nrf2\/HO-1 signaling in BV2 and primary microglial cells","volume":"143","author":"Kim","year":"2020","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.steroids.2025.109588_b0040","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neuint.2017.01.018","article-title":"Capillarisin augments anti-oxidative and anti-inflammatory responses by activating Nrf2\/HO-1 signaling","volume":"105","author":"Kim","year":"2017","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.steroids.2025.109588_b0045","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1021\/acschemneuro.5b00256","article-title":"Accessible method for the development of novel sterol analogues with dipeptide-like side chains that act as neuroinflammation inhibitors","volume":"7","author":"Chen","year":"2016","journal-title":"ACS Chem. Nerosci."},{"key":"10.1016\/j.steroids.2025.109588_b0050","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/WCO.0b013e3280adc943","article-title":"Therapeutic approaches to inflammation in neurodegenerative disease","volume":"20","author":"Klegeris","year":"2007","journal-title":"Curr. Opin. Neurol."},{"issue":"7","key":"10.1016\/j.steroids.2025.109588_b0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0103969","article-title":"Anti-inflammatory effects of progesterone in lipopolysaccharide-stimulated BV-2 microglia","volume":"9","author":"Lei","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.steroids.2025.109588_b0060","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/jnr.490310405","article-title":"An immortalized cell line expresses properties of activated microglial cells","volume":"31","author":"Bocchini","year":"1992","journal-title":"J. Neurosci. Res."},{"issue":"2","key":"10.1016\/j.steroids.2025.109588_b0065","first-page":"83","article-title":"The suitability of BV2 cells as alternative model system for primary microglia cultures or for animal experiments examining brain inflammation","volume":"26","author":"Henn","year":"2009","journal-title":"Altex-Altern Anim. Ex"},{"issue":"7343","key":"10.1016\/j.steroids.2025.109588_b0070","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/nature09788","article-title":"Caspase signalling controls microglia activation and neurotoxicity","volume":"472","author":"Burguillos","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.steroids.2025.109588_b0075","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jphs.2018.02.004","article-title":"Neurotropin inhibits neuroinflammation via suppressing NF-\u03baB and MAPKs signaling pathways in lipopolysaccharide-stimulated BV2 cells","volume":"136","author":"Zheng","year":"2018","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.steroids.2025.109588_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114322","article-title":"Anti-neuroinflammatory effects of novel 5,6-dihydrobenzo[h] quinazolin-2-amine derivatives in lipopolysaccharide-stimulated BV2 microglial cells","volume":"235","author":"Zhang","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.steroids.2025.109588_b0085","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ejmech.2018.02.063","article-title":"Design, synthesis, and biological evaluation of compounds with a new scaffold as anti-neuroinflammatory agents for the treatment of Alzheimer's disease","volume":"149","author":"Fang","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"1\u20132","key":"10.1016\/j.steroids.2025.109588_b0090","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11010-012-1445-1","article-title":"Homeostatic regulatory role of Pokemon in NF-\u03baB signaling: stimulating both p65 and I\u03baB\u03b1 expression in human hepatocellular carcinoma cells","volume":"372","author":"Zhang","year":"2013","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.steroids.2025.109588_b0095","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.intimp.2013.11.020","article-title":"Downregulation of NO and PGE2 in LPS-stimulated BV2 microglial cells by trans-isoferulic acid via suppression of PI3K\/Akt-dependent NF-\u03baB and activation of Nrf2-mediated HO-1","volume":"18","author":"Dilshara","year":"2014","journal-title":"Int. Immunopharmacol."},{"issue":"5","key":"10.1016\/j.steroids.2025.109588_b0100","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/cmi.2009.43","article-title":"NF-\u03baB signaling pathway, inflammation and colorectal cancer","volume":"6","author":"Wang","year":"2009","journal-title":"Cell. Mol. Immunol."},{"issue":"5","key":"10.1016\/j.steroids.2025.109588_b0105","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1248\/bpb.b15-00572","article-title":"Chikusetsusaponin IVa methyl ester isolated from the roots of Achyranthes japonica suppresses LPS-Induced iNOS, TNF-\u03b1, IL-6, and IL-1\u03b2 expression by NF-\u03baB and AP-1 inactivation","volume":"39","author":"Lee","year":"2016","journal-title":"Biol. Pharm. Bull."},{"issue":"7","key":"10.1016\/j.steroids.2025.109588_b0110","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1128\/MCB.24.7.3048-3056.2004","article-title":"Inhibition of NF-\u03baB activity by I\u03baB\u03b2 in association with \u03baB-Ras","volume":"24","author":"Chen","year":"2004","journal-title":"Mol. Cell Biol."},{"issue":"2","key":"10.1016\/j.steroids.2025.109588_b0115","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1172\/JCI11914","article-title":"Therapeutic potential of inhibition of the NF-\u03baB pathway in the treatment of inflammation and cancer","volume":"107","author":"Yamamoto","year":"2001","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.steroids.2025.109588_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113743","article-title":"Design, synthesis, and SAR study of novel 4,5-dihydropyrazole-Thiazole derivatives with anti-inflammatory activities for the treatment of sepsis","volume":"225","author":"Zhang","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.steroids.2025.109588_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113766","article-title":"Design, synthesis and structure-activity relationship studies of 4-indole-2-arylaminopyrimidine derivatives as anti-inflammatory agents for acute lung injury","volume":"225","author":"Chen","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.steroids.2025.109588_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.107928","article-title":"2-(5-(4-Chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazol-3-yl)-N-(2-hydroxyethyl)-2-oxoacetamide (CDMPO) has anti-inflammatory properties in microglial cells and prevents neuronal and behavioral deficits in MPTP mouse model of Parkinson's disease","volume":"166","author":"Kim","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.steroids.2025.109588_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2022.129061","article-title":"Synthesis of 1-(5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazol-3-yl)-2-morpholinoethane-1,2-dione analogues and their inhibitory activities with reduced cytotoxicity in lipopolysaccharide-induced BV2 cells","volume":"79","author":"Yoon","year":"2023","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"6","key":"10.1016\/j.steroids.2025.109588_b0140","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1039\/c001262a","article-title":"Steroids: partial synthesis in medicinal chemistry","volume":"27","author":"Hanson","year":"2010","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.steroids.2025.109588_b0145","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.neuroscience.2011.06.076","article-title":"Pregnenolone as a novel therapeutic candidate in schizophrenia: Emerging preclinical and clinical evidence","volume":"191","author":"Marx","year":"2011","journal-title":"Neuroscience"},{"issue":"12","key":"10.1016\/j.steroids.2025.109588_b0150","doi-asserted-by":"crossref","first-page":"4596","DOI":"10.1074\/jbc.RA118.005543","article-title":"The neurosteroid pregnenolone promotes degradation of key proteins in the innate immune signaling to suppress inflammation","volume":"294","author":"Murugan","year":"2019","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.steroids.2025.109588_b0155","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jsbmb.2005.07.006","article-title":"Dehydroepiandrosterone (DHEA) metabolism in the brain: Identification by liquid chromatography\/mass spectrometry of the delta-4-isomer of DHEA and related steroids formed from androstenedione by mouse BV2 microglia","volume":"98","author":"Jellinck","year":"2006","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.steroids.2025.109588_b0160","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1016\/j.bmcl.2012.01.103","article-title":"Synthesis and biological evaluation of 21-arylidenepregnenolone derivatives as neuroprotective agents","volume":"22","author":"Jiang","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.steroids.2025.109588_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.steroids.2022.109113","article-title":"Synthesis of steroidal dihydropyrazole derivatives using green ZnO NPs and evaluation of their anticancer and antioxidant activity","volume":"188","author":"Ansari","year":"2022","journal-title":"Steroids"},{"key":"10.1016\/j.steroids.2025.109588_b0170","doi-asserted-by":"crossref","first-page":"31607","DOI":"10.1038\/srep31607","article-title":"Structurally novel steroidal spirooxindole by241 potently inhibits tumor growth mainly through ROS-mediated mechanisms","volume":"6","author":"Shi","year":"2016","journal-title":"Sci. Rep.-Uk"},{"key":"10.1016\/j.steroids.2025.109588_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104827","article-title":"Design, synthesis and molecular docking of new pyrazole-thiazolidinones as potent anti-inflammatory and analgesic agents with TNF-\u03b1 inhibitory activity","volume":"111","author":"Abd El-Karim","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.steroids.2025.109588_b0180","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3389\/fchem.2018.00098","article-title":"Design, synthesis, and evaluation of dihydrobenzo[cd] indole-6-sulfonamide as TNF-\u03b1 inhibitors","volume":"6","author":"Deng","year":"2018","journal-title":"Front. Chem."},{"key":"10.1016\/j.steroids.2025.109588_b0185","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jsbmb.2019.02.006","article-title":"Synthesis and antimicrobial properties of steroid-based imidazolium salts","volume":"189","author":"Hryniewicka","year":"2019","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.steroids.2025.109588_b0190","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ijantimicag.2008.03.019","article-title":"Synthesis and in vitro antimycobacterial activity of 3-substituted 5-hydroxy-5-trifluoro[chloro]methyl-4,5-dihydro-1H-1-(isonicotinoyl) pyrazoles","volume":"32","author":"da Silva","year":"2008","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.steroids.2025.109588_b0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2022.116882","article-title":"Recent advances on synthesis and biological activities of C-17 aza-heterocycle derived steroids","volume":"69","author":"Huo","year":"2022","journal-title":"Bioorg. Med. Chem."},{"issue":"7","key":"10.1016\/j.steroids.2025.109588_b0200","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.3390\/molecules26072032","article-title":"Highlights on steroidal arylidene derivatives as a source of pharmacologically active compounds: a review","volume":"26","author":"Brito","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.steroids.2025.109588_b0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2022.132818","article-title":"Synthesis, DFT study, molecular docking and drug-likeness analysis of the heteroaryl substituted new pregnenolone derivatives","volume":"1260","author":"Capan","year":"2022","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.steroids.2025.109588_b0210","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.ijbiomac.2012.02.006","article-title":"Steroidal pyrazolines evaluated as aromatase and quinone reductase-2 inhibitors for chemoprevention of cancer","volume":"50","author":"Abdalla","year":"2012","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.steroids.2025.109588_b0215","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.steroids.2019.03.012","article-title":"Synthesis and evaluation of novel D-ring substituted steroidal pyrazolines as potential anti-inflammatory agents","volume":"146","author":"Cai","year":"2019","journal-title":"Steroids"},{"key":"10.1016\/j.steroids.2025.109588_b0220","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jscs.2012.05.004","article-title":"Rehman, Synthesis, characterization, antimicrobial and anticancer studies of new steroidal pyrazolines","volume":"20","author":"Shamsuzzaman","year":"2016","journal-title":"J. Saudi Chem. Soc."},{"key":"10.1016\/j.steroids.2025.109588_b0225","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ejmech.2013.08.016","article-title":"Synthesis and cytotoxic activity of some novel steroidal C-17 pyrazolinyl derivatives","volume":"69","author":"Fan","year":"2013","journal-title":"Eur. J. Med. Chem."},{"issue":"5","key":"10.1016\/j.steroids.2025.109588_b0230","doi-asserted-by":"crossref","first-page":"348","DOI":"10.2174\/1385272823666191021124443","article-title":"Molecular Hybridization as a Tool in the design of multi-target directed drug candidates for neurodegenerative diseases","volume":"18","author":"Gontijo","year":"2020","journal-title":"Curr. Neuropharmacol."},{"issue":"17","key":"10.1016\/j.steroids.2025.109588_b0235","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.2174\/092986707781058805","article-title":"Molecular hybridization: a useful tool in the design of new drug prototypes","volume":"14","author":"Viegas-Junior","year":"2007","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.steroids.2025.109588_b0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115417","article-title":"Design, synthesis, and SAR study of novel flavone 1,2,4-oxadiazole derivatives with anti-inflammatory activities for the treatment of Parkinson's disease","volume":"255","author":"Shen","year":"2023","journal-title":"Eur. J. Med. Chem."},{"issue":"2","key":"10.1016\/j.steroids.2025.109588_b0245","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.steroids.2025.109588_b0250","doi-asserted-by":"crossref","first-page":"W5","DOI":"10.1093\/nar\/gkab255","article-title":"ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties","volume":"49","author":"Xiong","year":"2021","journal-title":"Nucl. Acids Res."},{"key":"10.1016\/j.steroids.2025.109588_b0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103233","article-title":"Anti-inflammatory flavonoids from root bark of Broussonetia papyrifera in LPS-stimulated RAW 264.7 cells","volume":"92","author":"Ryu","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.steroids.2025.109588_b0260","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.pnpbp.2015.06.008","article-title":"The role of pro-inflammatory cytokines in neuroinflammation, neurogenesis and the neuroendocrine system in major depression","volume":"64","author":"Kim","year":"2016","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"25","key":"10.1016\/j.steroids.2025.109588_b0265","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.2174\/138161210793176572","article-title":"Neuroinflammation, oxidative stress and the pathogenesis of Alzheimer's disease","volume":"16","author":"Agostinho","year":"2010","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.steroids.2025.109588_b0270","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.0105-2896.2004.00180.x","article-title":"Manipulation of mitogen-activated protein kinase\/nuclear factor-\u03baB-signaling cascades during intracellular Toxoplasma gondii infection","volume":"201","author":"Denkers","year":"2004","journal-title":"Immunol. Rev."},{"issue":"15","key":"10.1016\/j.steroids.2025.109588_b0275","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/S0024-3205(01)00967-5","article-title":"NF-\u03baB activation and I\u03baB\u03b1 dynamism involved in iNOS and chemokine induction in astroglial cells","volume":"68","author":"Nomura","year":"2001","journal-title":"Life Sci."},{"key":"10.1016\/j.steroids.2025.109588_b0280","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2174\/1389450003349056","article-title":"The ubiquitin-dependent proteolytic system and other potential targets for the modulation of Nuclear Factor-\u03baB (NF-\u03baB)","volume":"1","author":"Magnani","year":"2000","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.steroids.2025.109588_b0285","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12931-015-0199-1","article-title":"Anti-inflammatory effects of novel curcumin analogs in experimental acute lung injury","volume":"16","author":"Zhang","year":"2015","journal-title":"Respir. Res."},{"issue":"1","key":"10.1016\/j.steroids.2025.109588_b0290","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1600-065X.2012.01104.x","article-title":"I\u03baB kinase regulation of the TPL-2\/ERK MAPK pathway","volume":"246","author":"Gantke","year":"2012","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.steroids.2025.109588_b0295","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.biopha.2019.01.017","article-title":"Anti-neuroinflammatory effect of Iresine celosia on lipopolysaccharide-stimulated microglial cells and mouse","volume":"111","author":"Kim","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.steroids.2025.109588_b0300","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0006-8993(00)02270-8","article-title":"Cyclopentenone prostaglandin 15-deoxy-Delta (12,14)-prostaglandin J (2) acts as a general inhibitor of inflammatory responses in activated BV-2 microglial cells","volume":"867","author":"Koppal","year":"2000","journal-title":"Brain Res."},{"issue":"9","key":"10.1016\/j.steroids.2025.109588_b0305","doi-asserted-by":"crossref","first-page":"6259","DOI":"10.1074\/jbc.275.9.6259","article-title":"Transcriptional activation of the cyclooxygenase-2 gene in endotoxin-treated RAW 264.7 macrophages","volume":"275","author":"Wadleigh","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.steroids.2025.109588_b0310","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2174\/138955708783331577","article-title":"Current status of COX-2 inhibitors","volume":"8","author":"Singh","year":"2008","journal-title":"Mini-Rev. Med. Chem."},{"issue":"6","key":"10.1016\/j.steroids.2025.109588_b0315","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/biof.1035","article-title":"COX-2 in the neurodegenerative process of Parkinson's disease","volume":"38","author":"Teismann","year":"2012","journal-title":"Biofactors"},{"issue":"6","key":"10.1016\/j.steroids.2025.109588_b0320","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1002\/glia.23587","article-title":"Lipopolysaccharide-induced alteration of mitochondrial morphology induces a metabolic shift in microglia modulating the inflammatory response in vitro and in vivo","volume":"67","author":"Nair","year":"2019","journal-title":"Glia"},{"key":"10.1016\/j.steroids.2025.109588_b0325","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.foodchem.2016.06.068","article-title":"Anti-neuroinflammatory activities of indole alkaloids from kanjang (Korean fermented soy source) in lipopolysaccharide-induced BV2 microglial cells","volume":"213","author":"Kim","year":"2016","journal-title":"Food Chem."}],"container-title":["Steroids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X25000297?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X25000297?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T09:11:07Z","timestamp":1741684267000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039128X25000297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":65,"alternative-id":["S0039128X25000297"],"URL":"https:\/\/doi.org\/10.1016\/j.steroids.2025.109588","relation":{},"ISSN":["0039-128X"],"issn-type":[{"value":"0039-128X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design and discovery of novel heteroaryl substituted pregnenolone derivatives as potent anti-neuroinflammatory agents targeting LPS-stimulated BV-2 microglial cells","name":"articletitle","label":"Article Title"},{"value":"Steroids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.steroids.2025.109588","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109588"}}